Jack L Bowman's Net Worth

$15 Million

Estimate Recalculated Sep 16, 2024 07:06PM EST

Who is Jack L Bowman?

Jack L Bowman has an estimated net worth of $15 Million. This is based on reported shares across multiple companies, which include AVI BIOPHARMA INC, NEORX CORP, CELGENE CORP /DE/, CELL THERAPEUTICS INC, TARGETED GENETICS CORP /WA/, and CELLEGY PHARMACEUTICALS INC.

SEC CIK

Jack L Bowman's CIK is 0001014094

Past Insider Trading and Trends

2003 was Jack L Bowman's most active year for acquiring shares with 15 total transactions. Jack L Bowman's most active month to acquire stocks was the month of April. 2003 was Jack L Bowman's most active year for disposing of shares, totalling 12 transactions. Jack L Bowman's most active month to dispose stocks was the month of October. 2007 saw Jack L Bowman paying a total of $672,400.00 for 118,375 shares, this is the most they've acquired in one year. In 2007 Jack L Bowman cashed out on 160,000 shares for a total of $4,736,632.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AVI BIOPHARMA INC (SRPT) Snapshot price: $128.92

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 22
Form 4
—
0
—
—
0
May 24
Form 4
∞
5K
$6.36
$31,800.00
5K
Mar 17
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
Mar 25
Form 3
—
0
—
—
0
No matching records found

NEORX CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+86.96%
10K
$2.47
$24,740.00
21.5K
Aug 7
Form 4
—
0
—
—
0
No matching records found

CELGENE CORP /DE/ No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 17
Form 4
—
0
$35.58
-$2,174,184.00
12K
May 7
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
$32.03
-$1,890,048.00
12K
Feb 9
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
$28.56
-$1,668,620.00
12K
Oct 30
Form 4
—
0
$25.99
-$1,726,364.00
12K
Jul 31
Form 4
—
0
$21.62
-$1,625,508.00
12K
May 1
Form 4
—
0
$36.64
-$1,361,678.00
6K
Feb 2
Form 4
—
0
$31.27
-$1,747,954.84
6K
Dec 28
Form 4
—
0
—
—
0
Dec 29
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
$20.61
-$753,480.00
6K
May 24
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
$15.59
-$1,105,564.00
3K
Oct 27
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
—
—
0
Jun 15
Form 4
—
0
—
—
0
Mar 15
Form 4
—
0
—
—
0
Dec 15
Form 4
—
0
—
—
0
Sep 15
Form 4
—
0
$21.14
-$351,983.00
3K
Sep 2
No matching records found

CELL THERAPEUTICS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 21
No matching records found

TARGETED GENETICS CORP /WA/ (ARMP) Snapshot price: $2.33

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+2,000.00%
10K
—
—
10.5K
May 17
Form 4
—
0
—
—
0
May 8
Form 4
—
0
—
—
0
May 26
Form 4
—
0
—
—
0
May 20
No matching records found